DXM (dextromethorphan)

The results of the 2020 National Institute on Drug Abuse (NIDA) and University of Michigan’s Monitoring the Future survey shows more teens reported using OTC cough medicine containing DXM to get high than in 2019.

There is currently no clinical data indicating that dextromethorphan has a pro-viral effect in people with COVID-19 infection. The study results published in Nature are experimental, preliminary, and not conclusive.

The 2019 results from the NIDA and University of Michigan’s annual drug abuse survey, Monitoring the Future, show that the number of teens using OTC cough medicine containing DXM to get high decreased slightly.

Michigan Governor Gretchen Whitmer today signed HB 4412, legislation to combat teen abuse of OTC medicines containing the cough suppressant dextromethorphan (DXM).

The 2018 results from the National Institute on Drug Abuse and University of Michigan's annual drug abuse survey, Monitoring the Future, show that the percentage of teens using OTC cough medicine containing dextromethorphan to get high remains at three percent.

Yesterday, Pennsylvania Governor Tom Wolf signed into law HB 1951, legislation prohibiting the sale of over-the-counter (OTC) medicines containing the cough suppressant dextromethorphan (DXM) to minors.

CHPA applauds Colorado for enacting a law prohibiting the sale of over-the-counter (OTC) medicines containing the cough suppressant dextromethorphan (DXM) to minors this week.

Colorado Governor John Hickenlooper signed into law HB 1307, legislation prohibiting the sale of over-the-counter (OTC) medicines containing the cough suppressant dextromethorphan (DXM) to minors.